battle of glp 1 delivery technologies New Drug Approach for GLP-1 Drugs Designing GLP-1 delivery: structural perspectives

La fermentation utilise des micro-organismes capables de transformer des prcurseurs comme la trimthyllysine en L-carnitine grce une cascade enzymatique, tels qu' Escherichia coli

L-Carnitine (Carnicor) may decrease the need for certain drugs, such as glycosides, digoxin, diuretics, beta-blockers, channel blockers, hypolipidemic drugs, and nitro derivatives

Pineal peptides may be particularly helpful when stress interrupts sleep and reproductive rhythms

Moreover, in newly weaned piglets, dietary glutamine decreased the proportion of antigen-nave T cells in the mesenteric lymph nodes (153), which are reported to be elevated in allergic patients and are proposed as an early life marker for future development of allergies (154, 155)

[3] Malaguarnera M, Cauli O